House of Commons · Petition P002715
Sodium valproate
01 March 2022
Presented 1 time by 1 MP
Summarised by AI from the official record, so it can contain mistakes.
At a glance
This petition concerning sodium valproate was presented to Parliament once by 1 MP.
Issue summary
The petition addresses the negative impact of sodium valproate use during pregnancy, which has led to birth defects in children and calls for immediate action based on the Cumberlege Review findings.
Action requested
The House of Commons is urged to request that the Government immediately implement all recommendations from the Cumberlege Review regarding the use of sodium valproate in pregnancy.
Key facts
- Sodium valproate use during pregnancy has been linked to increased risk of developmental problems, spina bifida, cleft palate, limb defects and other serious birth defects.
- The petition is led by campaigners Janet Williams and Emma Murphy.
- The Cumberlege Review, authored by Baroness Julia Cumberlege, provides evidence for the risks associated with sodium valproate.
Presentation timeline
MPs presented this petition on the following dates. Each card shows the presenters and any recorded remarks.
-
Presented 01 March 2022
I rise to present a petition to the House of Commons from the residents of the United Kingdom on sodium valproate. This petition has been instigated by my constituent Janet Williams, who joins us in the Public Gallery this evening, along with Emma Murphy. They are long-time campaigners on the issue of sodium valproate in pregnancy, which has affected many children and caused a great many birth defects. The petition aims to raise awareness of the Cumberlege review, written by Baroness Julia Cumberlege, which found that the use of sodium valproate in pregnancy has been linked to an increased risk of developmental problems, spina bifida, cleft palate, limb defects and other serious birth defects. The petition states: